← Leaderboards
Abbey Masonbrink
Children'S Mercy Hosp (Kansas City, Mo)
$764,856
Attributed
$764,856
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $196.2K · FY2022–25$200K$150K$100K$50K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$764,856 · 1
By mechanism
K23$764,856 · 1
Top collaborators
No co-investigators on record.
Most similar at Children'S Mercy Hosp (Kansas City, Mo)
Same institution · by research overlap
- Bridgette L. Jones$4,441,214
Others in their field
Other Rising Stars on “Abstinence”
- Charles Daniel Meyers · Tempero Bio, Inc.$5,310,920
- Ian Gurrell · Astrazeneca Pharmaceuticals, Lp$5,256,914
- Mark Sorenson · Nirsum Laboratories, Inc.$4,866,388
- Glenn Short III · Atai Therapeutics, Inc.$2,923,842
- Georgette Suidan · Cerevel Therapeutics, Llc$2,700,000
- Omar El-Shahawy · New York University School Of Medicine$2,623,868
Research focus
AbstinenceContextual FactorsAcademyAdolescentAcuteAdultAdolescenceAlcohol ConsumptionAlcoholsAmericanAsthmaAdolescent And Young AdultBehavior TherapyBiochemicalCare CoordinationCaringCigaretteCigarette SmokingCombustible CigaretteComorbidityComplexComputerizedConsolidated Framework For Implementation ResearchCounseling
Grant awards (4)
Development and Implementation of a Tobacco and ENDS Use Intervention for Adolescents and Young Adults in the Pediatric Hospital$196,236
K23 · FY2025 · DA · contact PI
Development and Implementation of a Tobacco and ENDS Use Intervention for Adolescents and Young Adults in the Pediatric Hospital$189,540
K23 · FY2024 · DA · contact PI
Development and Implementation of a Tobacco and ENDS Use Intervention for Adolescents and Young Adults in the Pediatric Hospital$189,540
K23 · FY2023 · DA · contact PI
Development and Implementation of a Tobacco and ENDS Use Intervention for Adolescents and Young Adults in the Pediatric Hospital$189,540
K23 · FY2022 · DA · contact PI